[go: up one dir, main page]

NO963292D0 - Nye forbindelser med analgetisk og lokalanaestetisk effekt - Google Patents

Nye forbindelser med analgetisk og lokalanaestetisk effekt

Info

Publication number
NO963292D0
NO963292D0 NO963292A NO963292A NO963292D0 NO 963292 D0 NO963292 D0 NO 963292D0 NO 963292 A NO963292 A NO 963292A NO 963292 A NO963292 A NO 963292A NO 963292 D0 NO963292 D0 NO 963292D0
Authority
NO
Norway
Prior art keywords
new compounds
analgesic
local anesthetic
anesthetic effect
effect
Prior art date
Application number
NO963292A
Other languages
English (en)
Other versions
NO963292L (no
NO306718B1 (no
Inventor
Anna-Lena Ask
Rune Sandberg
Lars-Inge Olsson
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of NO963292L publication Critical patent/NO963292L/no
Publication of NO963292D0 publication Critical patent/NO963292D0/no
Publication of NO306718B1 publication Critical patent/NO306718B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/64—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having an aryl radical as the second substituent in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Anesthesiology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Finger-Pressure Massage (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO963292A 1994-02-11 1996-08-07 Nye forbindelser med analgetisk og lokalanaestetisk effekt, farmasöytisk preparat inneholdende disse forbindelsene og deres anvendelse NO306718B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9400447A SE9400447D0 (sv) 1994-02-11 1994-02-11 New compounds
PCT/SE1995/000106 WO1995021821A1 (en) 1994-02-11 1995-02-03 New compounds with analgesic and local anaesthetic effect

Publications (3)

Publication Number Publication Date
NO963292L NO963292L (no) 1996-08-07
NO963292D0 true NO963292D0 (no) 1996-08-07
NO306718B1 NO306718B1 (no) 1999-12-13

Family

ID=20392881

Family Applications (1)

Application Number Title Priority Date Filing Date
NO963292A NO306718B1 (no) 1994-02-11 1996-08-07 Nye forbindelser med analgetisk og lokalanaestetisk effekt, farmasöytisk preparat inneholdende disse forbindelsene og deres anvendelse

Country Status (31)

Country Link
US (2) US5756520A (no)
EP (1) EP0743940B1 (no)
JP (1) JPH09508904A (no)
CN (1) CN1067989C (no)
AT (1) ATE192435T1 (no)
AU (1) AU686760B2 (no)
BR (1) BR9506748A (no)
CA (1) CA2181068A1 (no)
CZ (1) CZ286753B6 (no)
DE (1) DE69516671T2 (no)
DK (1) DK0743940T3 (no)
EE (1) EE03252B1 (no)
ES (1) ES2148493T3 (no)
FI (1) FI963128A7 (no)
GR (1) GR3033999T3 (no)
HR (1) HRP950414B1 (no)
HU (1) HU216734B (no)
IL (1) IL112374A (no)
IS (1) IS1771B (no)
MX (1) MX9603092A (no)
MY (1) MY130166A (no)
NO (1) NO306718B1 (no)
NZ (1) NZ281355A (no)
PL (1) PL180212B1 (no)
PT (1) PT743940E (no)
RU (1) RU2145599C1 (no)
SE (1) SE9400447D0 (no)
SK (1) SK281931B6 (no)
TW (1) TW348176B (no)
WO (1) WO1995021821A1 (no)
ZA (1) ZA95709B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9523526D0 (en) * 1995-11-17 1996-01-17 Zeneca Ltd Therapeutic compounds
US7799337B2 (en) 1997-07-21 2010-09-21 Levin Bruce H Method for directed intranasal administration of a composition
DE19912889A1 (de) * 1999-03-23 2000-09-28 Daimler Chrysler Ag Verfahren zur Herstellung eines Ventilsitzes
US7645771B2 (en) * 2002-12-13 2010-01-12 Smithkline Beecham Corp. CCR5 antagonists as therapeutic agents
US6916833B2 (en) * 2003-03-13 2005-07-12 Hoffmann-La Roche Inc. Substituted piperidines
FR2861074B1 (fr) * 2003-10-17 2006-04-07 Sanofi Synthelabo Derives de n-[phenyl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique
CL2007002958A1 (es) * 2006-10-12 2008-05-09 Epix Delaware Inc Compuestos derivados de heteroaril-carboxamida, antagonistas del receptor de quimioquina; composicion farmaceutica; y uso para el tratamiento o prevencion de enfermedades tales como rechazo de transplante de organos, artritis reumatoidea, lupus, entr
JP2011506466A (ja) 2007-12-11 2011-03-03 株式会社サイトパスファインダー カルボキサミド化合物ならびにケモカイン受容体アゴニストとしてのそれらの使用
US8473062B2 (en) * 2008-05-01 2013-06-25 Autonomic Technologies, Inc. Method and device for the treatment of headache
US8412336B2 (en) * 2008-12-29 2013-04-02 Autonomic Technologies, Inc. Integrated delivery and visualization tool for a neuromodulation system
US8494641B2 (en) 2009-04-22 2013-07-23 Autonomic Technologies, Inc. Implantable neurostimulator with integral hermetic electronic enclosure, circuit substrate, monolithic feed-through, lead assembly and anchoring mechanism
US9320908B2 (en) * 2009-01-15 2016-04-26 Autonomic Technologies, Inc. Approval per use implanted neurostimulator
US20100185249A1 (en) * 2009-01-22 2010-07-22 Wingeier Brett M Method and Devices for Adrenal Stimulation
WO2020152212A1 (en) 2019-01-22 2020-07-30 Icm (Institut Du Cerveau Et De La Moelle Épinière) Local anesthetic for the treatment of neurological symptoms resulting from brain dysfunctions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2951080A (en) * 1957-08-05 1960-08-30 Lilly Co Eli Novel phenyl-substituted piperidines
NL262366A (no) * 1960-03-14
US3850935A (en) * 1971-10-16 1974-11-26 Sumitomo Chemical Co Process for producing piperidine derivatives by degrading quaternary piperidinium salts
US4369184A (en) * 1980-01-24 1983-01-18 Janssen Pharmaceutica N.V. 1-(Cyclohexyl)-4-aryl-4-piperidinecarboxylic acid derivatives
SE8904298D0 (sv) * 1989-12-21 1989-12-21 Astra Ab New compounds
EP0673367A1 (en) * 1992-12-14 1995-09-27 MERCK SHARP & DOHME LTD. 4-aminomethyl/thiomethyl/sulfonylmethyl-4-phenylpiperidines as tachykinin receptor antagonists

Also Published As

Publication number Publication date
AU686760B2 (en) 1998-02-12
NO963292L (no) 1996-08-07
RU2145599C1 (ru) 2000-02-20
GR3033999T3 (en) 2000-11-30
IS1771B (is) 2001-05-28
PT743940E (pt) 2000-08-31
FI963128L (fi) 1996-08-09
MY130166A (en) 2007-06-29
MX9603092A (es) 1997-03-29
US5756520A (en) 1998-05-26
CZ286753B6 (en) 2000-06-14
ES2148493T3 (es) 2000-10-16
HRP950414A2 (en) 1997-10-31
SK281931B6 (sk) 2001-09-11
PL315777A1 (en) 1996-12-09
CA2181068A1 (en) 1995-08-17
WO1995021821A1 (en) 1995-08-17
HU9602206D0 (en) 1996-10-28
FI963128A0 (fi) 1996-08-09
TW348176B (en) 1998-12-21
FI963128A7 (fi) 1996-08-09
SK92896A3 (en) 1997-07-09
EP0743940A1 (en) 1996-11-27
SE9400447D0 (sv) 1994-02-11
IS4251A (is) 1995-08-12
DE69516671D1 (de) 2000-06-08
EE03252B1 (et) 2000-02-15
IL112374A (en) 1999-12-31
ATE192435T1 (de) 2000-05-15
JPH09508904A (ja) 1997-09-09
AU1826995A (en) 1995-08-29
DK0743940T3 (da) 2000-08-14
EP0743940B1 (en) 2000-05-03
CN1140448A (zh) 1997-01-15
CZ203296A3 (en) 1996-12-11
BR9506748A (pt) 1997-09-16
PL180212B1 (pl) 2001-01-31
HU216734B (hu) 1999-08-30
CN1067989C (zh) 2001-07-04
IL112374A0 (en) 1995-03-30
NZ281355A (en) 1998-02-26
NO306718B1 (no) 1999-12-13
DE69516671T2 (de) 2001-02-01
ZA95709B (en) 1995-08-11
US5968953A (en) 1999-10-19
HRP950414B1 (en) 2001-02-28
HUT75641A (en) 1997-05-28

Similar Documents

Publication Publication Date Title
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
IS3659A7 (is) Ný aðferð við að framleiða útskipt 4-fenýl-4-píperídínkarboxamíð sem hefur bæði staðbundin deyfandi og kvalastillandi áhrif
DK0743940T3 (da) Nye forbindelser med analgetisk og local-anæstetisk virkning
SE9401728D0 (sv) New compounds II
MA23170A1 (fr) Procede de preparation d'un nouveau compose .
MY119403A (en) Novel compounds with analgesic effect.
MY130773A (en) Stable extended release oral dosage composition
ES2102475T3 (es) Nuevas alquil-amidas heterociclicas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
MY108146A (en) Medicaments for treating inflammatory conditions or for analgesia
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
NO993921D0 (no) Medikament mot infertilitet og for ökt fertilitet
NO903291L (no) Renin-hemmende aminooligohydroksyderivater.
JO1652B1 (en) New compounds for local anesthesia and a way to prepare them
GR900100108A (el) Νεες ενωσεις τοπικης αναισθησιας και μεθοδος για την παρασκευη τους.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN AUGUST 2002